Mitochondrial pathology in Parkinson's disease and implications for therapeutic intervention

被引:0
|
作者
Swerdlow, RH [1 ]
Parker, WD [1 ]
机构
[1] Univ Virginia, Hlth Sci Ctr, Dept Neurol, Charlottesville, VA 22908 USA
关键词
mitochondria; Parkinson's disease; mitochondrial DNA; therapy;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Although the ultimate origin and role of mitochondrial pathology in Parkinson's disease (PD) remains controversial, accumulating data suggest that mitochondrial dysfunction is genetic and plays an important role in neurodegeneration. PD mitochondria display abnormal electron transport chain activity, increased reactive oxygen species generation, and abnormal calcium handling. These abnormalities arise, at least in part, from information encoded by mitochondrial DNA. These processes are implicated in current models of neuronal death and validate ongoing efforts to develop mitochondrial-level pharmacologic interventions for the treatment of this disease. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:44 / 50
页数:7
相关论文
共 50 条
  • [11] Glucocerebrosidase Mutations Cause Mitochondrial and Lysosomal Dysfunction in Parkinson's Disease: Pathogenesis and Therapeutic Implications
    Zheng, Wei
    Fan, Dongsheng
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [12] Mitophagy in Parkinson's Disease: Pathogenic and Therapeutic Implications
    Gao, Fei
    Yang, Jia
    Wang, Dongdong
    Li, Chao
    Fu, Yi
    Wang, Huaishan
    He, Wei
    Zhang, Jianmin
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [13] The Genetics of Parkinson's Disease: Progress and Therapeutic Implications
    Singleton, Andrew B.
    Farrer, Matthew J.
    Bonifati, Vincenzo
    MOVEMENT DISORDERS, 2013, 28 (01) : 14 - 23
  • [14] Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications
    Pajares, Marta
    Rojo, Ana, I
    Manda, Gina
    Bosca, Lisardo
    Cuadrado, Antonio
    CELLS, 2020, 9 (07)
  • [15] Mitochondrial Dysfunction and Parkinson's Disease: Pathogenesis and Therapeutic Strategies
    Moradi Vastegani, Sadegh
    Nasrolahi, Ava
    Ghaderi, Shahab
    Belali, Rafie
    Rashno, Masome
    Farzaneh, Maryam
    Khoshnam, Seyed Esmaeil
    NEUROCHEMICAL RESEARCH, 2023, 48 (08) : 2285 - 2308
  • [16] Mitochondrial Dysfunction and Parkinson’s Disease: Pathogenesis and Therapeutic Strategies
    Sadegh Moradi Vastegani
    Ava Nasrolahi
    Shahab Ghaderi
    Rafie Belali
    Masome Rashno
    Maryam Farzaneh
    Seyed Esmaeil Khoshnam
    Neurochemical Research, 2023, 48 : 2285 - 2308
  • [17] Mitochondrial dysfunction and oxidative damage in the molecular pathology of Parkinson’s disease
    M. I. Shadrina
    P. A. Slominsky
    Molecular Biology, 2008, 42
  • [18] Mitochondrial Dysfunction and Oxidative Damage in the Molecular Pathology of Parkinson's Disease
    Shadrina, M. I.
    Slominsky, P. A.
    MOLECULAR BIOLOGY, 2008, 42 (05) : 720 - 728
  • [19] Impact of Belief in Neuroprotection on Therapeutic Intervention in Parkinson's Disease
    Elble, Rodger J.
    Suchowersky, Oksana
    Shaftman, Stephanie
    Weiner, William J.
    Huang, Pena
    Tilley, Barbara
    MOVEMENT DISORDERS, 2010, 25 (08) : 1082 - 1086
  • [20] Role of mitochondrial dysfunction in Parkinson's disease - Implications for treatment
    Ramsey, Chenere P.
    Giasson, Benoit I.
    DRUGS & AGING, 2007, 24 (02) : 95 - 105